Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Chrysant

Showing results (51-60 of 108) with videos related to

Pageof 11
Sort By:
Cardiology|January 1, 1991
Cardiac changes from beta-blocker, diuretic and minoxidil combination in hypertensionS G Chrysant, C Chrysant, M Sadeghi, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|February 1, 1981
The mechanism for the renal hemodynamic and tubular action of furosemideS G Chrysant, P R Baxter, R L Amonette
Nephron|January 1, 1980
Renal functional and organic changes induced by salt and prostaglandin inhibition in spontaneously hypertensive ratsS G Chrysant, A K Mandal, J A Nordquist
Archives of Internal Medicine|March 1, 1983
Severe reversible azotemia from captopril therapy. Report of three cases and review of the literatureS G Chrysant, M Dunn, D Marples, et al.
Journal of Clinical Pharmacology|March 1, 1985
A comparative study of captopril and enalapril in patients with severe hypertensionS G Chrysant, I S Bal, B Johnson, et al.
American Heart Journal|September 1, 1976
Systemic and renal hemodynamic effects of bupicomide: a new vasodilatorS G Chrysant, P Adamopoulos, M Tsuchiya, et al.
Circulation|July 1, 1975
Systemic hemodynamic effects of bethanidine in essential hypertensionS G Chrysant, K Nishiyama, P N Adamopoulos, et al.
JAMA|June 21, 1976
Letter: Withdrawal of clonidineT L Whitsett, S G Chrysant, B Dillard, et al.
Clinical Pharmacology and Therapeutics|November 1, 1981
Long-term hemodynamic and metabolic effects of trimazosin in essential hypertensionS G Chrysant, R F Miller, J L Brown, et al.
Journal of Human Hypertension|February 19, 2010
Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertensionS G Chrysant, J Lee, M Melino, et al.
Pageof 11

Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
Cardiology|January 1, 1991
Cardiac changes from beta-blocker, diuretic and minoxidil combination in hypertensionS G Chrysant, C Chrysant, M Sadeghi, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|February 1, 1981
The mechanism for the renal hemodynamic and tubular action of furosemideS G Chrysant, P R Baxter, R L Amonette
Nephron|January 1, 1980
Renal functional and organic changes induced by salt and prostaglandin inhibition in spontaneously hypertensive ratsS G Chrysant, A K Mandal, J A Nordquist
Archives of Internal Medicine|March 1, 1983
Severe reversible azotemia from captopril therapy. Report of three cases and review of the literatureS G Chrysant, M Dunn, D Marples, et al.
Journal of Clinical Pharmacology|March 1, 1985
A comparative study of captopril and enalapril in patients with severe hypertensionS G Chrysant, I S Bal, B Johnson, et al.
American Heart Journal|September 1, 1976
Systemic and renal hemodynamic effects of bupicomide: a new vasodilatorS G Chrysant, P Adamopoulos, M Tsuchiya, et al.
Circulation|July 1, 1975
Systemic hemodynamic effects of bethanidine in essential hypertensionS G Chrysant, K Nishiyama, P N Adamopoulos, et al.
JAMA|June 21, 1976
Letter: Withdrawal of clonidineT L Whitsett, S G Chrysant, B Dillard, et al.
Clinical Pharmacology and Therapeutics|November 1, 1981
Long-term hemodynamic and metabolic effects of trimazosin in essential hypertensionS G Chrysant, R F Miller, J L Brown, et al.
Journal of Human Hypertension|February 19, 2010
Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertensionS G Chrysant, J Lee, M Melino, et al.
Pageof 11